Zhenwei Yu

18PUBLICATIONS
12CO-AUTHORS
Epidemiological modellingPharmacogenomicsPharmacology and pharmaceutical sciences not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 26, 2026
Toward Model-Informed Precision Dosing of Imipenem: Multicenter External Validation of Population Pharmacokinetic Models in Adult Critically Ill Patients.

|Dec 15, 2025
Efficacy and Safety of Clobazam Adjunctive Therapy in Pediatric Patients with Drug-Resistant Epilepsy.

Lingyan Yu, Shunan Chen, Zhou Zhang

|Nov 17, 2025
Population Pharmacokinetics of Tigecycline and Implications for Individualized Therapy Optimization: A Systematic Review.

Anran Dai, Feiyue Zheng, Jieqiong Liu

|Apr 28, 2025
Development and Validation of a Population Pharmacokinetics Model of Perampanel for Pediatric Epilepsy Patients for Optimized Dosing.

Lingyan Yu, Fengqian Mao, Shunan Chen

|Mar 06, 2025
Clinical outcomes and pharmacokinetics/pharmacodynamics of intravenous polymyxin B treatment for various site carbapenem-resistant gram-negative bacterial infections: a prospective observational multicenter study.

Zhenwei Yu, Huangdu Hu, Xiaofen Liu

|Dec 12, 2024
Prescribing Trends of Fixed-Dose Combination Antibiotics Not Recommended by the WHO (FNRs) for ICU Patients in Six Major Areas of China During a Seven-Year Period.

Liujun Zhou, Yuhua Zhao, Jianping Zhu

Pageof 3

Frequent Collaborators

4 joint publications

Lingyan Yu

4 joint publications

Jieqiong Liu

3 joint publications

Jianping Zhu

2 joint publications

Haibin Dai